<qa>  What is the 18 WEEK STUDY OF LINAGLIPTIN?RANDOMIZED, DOUBLE-BLIND DB, PLACEBO-CONTROLLED 18 WEEK STUDY OF LINAGLIPTIN BI 1356 IN TYPE 2 DIABETIC PATIENTS WITH INSUFFICIENT GLYCAEMIC CONTROL ON A SULFONYLUREA DRUG: 